• 1
    Roberts EA, Schilsky ML. A practice guideline on Wilson disease. HEPATOLOGY 2003; 37: 14751492.
  • 2
    Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. HEPATOLOGY 2008; 47: 20892111.
  • 3
    Walshe JM, Yealland M. Chelation treatment of neurological Wilson's disease. Q J Med 1993; 86: 197204.
  • 4
    Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987; 44: 490493.
  • 5
    Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral zinc therapy for Wilson's disease. Ann Intern Med 1983; 99: 314319.
  • 6
    Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998; 132: 264278.
  • 7
    Czlonkowska A, Gajda J, Rodo M. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol 1996; 243: 269273.
  • 8
    Hoogenraad TU, van Hattum J, Van den Hamer CJ. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci 1987; 77: 137146.
  • 9
    Hoogenraad TU, Koevoet R, de Ruyter Korver EG. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979; 18: 205211.
  • 10
    Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006; 28: 141146.
  • 11
    Wu ZY, Lin MT, Murong SX, Wang N. Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients with Wilson disease. Arch Neurol 2003; 60: 737741.
  • 12
    Marcellini M, Di Clommo V, Callea F, Devito R, Comparcola D, Sartorelli MR, et al. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med 2005; 145: 139143.
  • 13
    Alexiou D, Hatzis T, Koutselinis A. Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years. [in French] Arch Fr Pediatr 1985; 42: 447449.
  • 14
    Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 1957; 2: 200215.
  • 15
    van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996; 198: 531536.
  • 16
    Medici V, Trevisan CP, D'Inca R, Barollo M, Zancan L, Fagiuoli S, et al. Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol 2006; 40: 936941.
  • 17
    Wiggelinkhuizen M, Tilanus ME, Bollen CW, Houwen RH. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009; 29: 947958.